Literature DB >> 1659248

Luminescent immobilized enzyme test systems for inorganic pyrophosphate: assays using firefly luciferase and nicotinamide-mononucleotide adenylyl transferase or adenosine-5'-triphosphate sulfurylase.

B A Barshop1, D T Adamson, D C Vellom, F Rosen, B L Epstein, J E Seegmiller.   

Abstract

Inorganic pyrophosphate was measured by luminescence produced by a pyrophosphatase (NAD adenylyl-transferase or ATP sulfurylase) coimmobilized with firefly luciferase on Sepharose beads, with continuous flow of saturating concentrations of substrates (NAD plus luciferin or adenylophosphosulfate plus luciferin, respectively) and intermittent injections of samples containing pyrophosphate. In this scheme, the limiting substrate (pyrophosphate) is regenerated, a situation that is well suited to a bioluminescent assay. The instrumentation allowed for automation with a through-put of approximately one sample every 4 min. With standard solutions or samples that do not contain ATP, the sensitivity of the assay permits detection of less than 1 pmol pyrophosphate in a volume of 20 microliters (50 nmol/liter) with a coefficient of variation approximately equal to 4%. To assay biological samples, it was shown that endogenous ATP can be inactivated by oxidation with sodium periodate. Periodate treatment and quenching engenders dilution that limits the sensitivity to approximately 600 nmol/liter pyrophosphate in the starting material. The assay has been applied to the determination of intracellular pyrophosphate in human lymphocytes and to the measurement of nucleoside-triphosphate pyrophosphohydrolase in human fibroblasts. The variability of the assay was greater with biological samples than with standard samples, with a coefficient of variation of 15.3% in a series of determinations of intracellular pyrophosphate in a series of replicate lymphocyte lysates. Bioluminescent systems of coupled coimmobilized enzymes offer great promise for sensitive, safe, automated assaying of metabolites.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1659248     DOI: 10.1016/0003-2697(91)90387-9

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  10 in total

1.  Understanding the molecular mechanism of sequence dependent tenofovir removal by HIV-1 reverse transcriptase: differences in primer binding site versus polypurine tract.

Authors:  Pinar Iyidogan; Karen S Anderson
Journal:  Antiviral Res       Date:  2012-06-01       Impact factor: 5.970

2.  A new proofreading mechanism for lesion bypass by DNA polymerase-λ.

Authors:  Emmanuele Crespan; Giovanni Maga; Ulrich Hübscher
Journal:  EMBO Rep       Date:  2011-12-23       Impact factor: 8.807

3.  Efficient pyrophosphorolysis by a hepatitis B virus polymerase may be a primer-unblocking mechanism.

Authors:  S Urban; S Urban; K P Fischer; D L Tyrrell
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-24       Impact factor: 11.205

4.  Correlation between viral resistance to zidovudine and resistance at the reverse transcriptase level for a panel of human immunodeficiency virus type 1 mutants.

Authors:  J Lennerstrand; K Hertogs; D K Stammers; B A Larder
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

5.  Fhit-nucleotide specificity probed with novel fluorescent and fluorogenic substrates.

Authors:  A Draganescu; S C Hodawadekar; K R Gee; C Brenner
Journal:  J Biol Chem       Date:  2000-02-18       Impact factor: 5.157

6.  Intracellular substrates for the primer-unblocking reaction by human immunodeficiency virus type 1 reverse transcriptase: detection and quantitation in extracts from quiescent- and activated-lymphocyte subpopulations.

Authors:  Anthony J Smith; Peter R Meyer; Deshratn Asthana; Margarita R Ashman; Walter A Scott
Journal:  Antimicrob Agents Chemother       Date:  2005-05       Impact factor: 5.191

7.  Unblocking of chain-terminated primer by HIV-1 reverse transcriptase through a nucleotide-dependent mechanism.

Authors:  P R Meyer; S E Matsuura; A G So; W A Scott
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-10       Impact factor: 11.205

8.  ATP-dependent removal of nucleoside reverse transcriptase inhibitors by human immunodeficiency virus type 1 reverse transcriptase.

Authors:  Lisa K Naeger; Nicolas A Margot; Michael D Miller
Journal:  Antimicrob Agents Chemother       Date:  2002-07       Impact factor: 5.191

9.  Metal-induced DNA translocation leads to DNA polymerase conformational activation.

Authors:  Thomas W Kirby; Eugene F DeRose; Nisha A Cavanaugh; William A Beard; David D Shock; Geoffrey A Mueller; Samuel H Wilson; Robert E London
Journal:  Nucleic Acids Res       Date:  2011-12-14       Impact factor: 16.971

10.  Utilization of a deoxynucleoside diphosphate substrate by HIV reverse transcriptase.

Authors:  Scott J Garforth; Michael A Parniak; Vinayaka R Prasad
Journal:  PLoS One       Date:  2008-04-30       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.